Maverick Capital Ltd. Buys Shares of 24,581 Sanofi $SNY

Maverick Capital Ltd. bought a new position in shares of Sanofi (NASDAQ:SNY) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund bought 24,581 shares of the company’s stock, valued at approximately $1,184,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Flagship Harbor Advisors LLC acquired a new stake in shares of Sanofi in the fourth quarter valued at about $25,000. Physician Wealth Advisors Inc. boosted its holdings in Sanofi by 180.5% during the first quarter. Physician Wealth Advisors Inc. now owns 589 shares of the company’s stock worth $28,000 after buying an additional 379 shares in the last quarter. Leonteq Securities AG grew its position in Sanofi by 95.8% during the first quarter. Leonteq Securities AG now owns 607 shares of the company’s stock worth $29,000 after buying an additional 297 shares during the period. Measured Wealth Private Client Group LLC purchased a new position in Sanofi in the third quarter valued at about $29,000. Finally, Palisade Asset Management LLC purchased a new position in Sanofi in the third quarter valued at about $30,000. 14.03% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Citigroup reissued a “neutral” rating on shares of Sanofi in a research note on Monday, April 13th. Weiss Ratings raised Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, May 13th. Argus raised Sanofi to a “strong-buy” rating in a report on Monday, April 27th. Morgan Stanley set a $49.00 target price on Sanofi in a research report on Wednesday, July 8th. Finally, Wall Street Zen cut Sanofi from a “buy” rating to a “hold” rating in a research report on Saturday, July 18th. Two investment analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $49.50.

Sanofi Stock Up 3.5%

SNY stock opened at $45.54 on Wednesday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.01 and a quick ratio of 0.22. The company’s 50 day simple moving average is $43.49 and its 200-day simple moving average is $45.29. Sanofi has a 12 month low of $40.89 and a 12 month high of $52.68. The firm has a market capitalization of $110.41 billion, a PE ratio of 12.72, a P/E/G ratio of 1.12 and a beta of 0.34.

About Sanofi

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.